Egalet competitors

Zippia score 4.2

Egalet main competitors are Salix Pharmaceuticals, Ortho Dermatologics, and Horizon Pharma USA, Inc.

Competitor Summary. See how Egalet compares to its main competitors:

Employees at Salix Pharmaceuticals earn more than most of the competitors, with an average yearly salary of $106,558.

Work at Egalet?

Share your experience

Egalet vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Egalet	1995	4.2	Wayne, PA	1	$79.5M	127
Topix Pharmaceuticals	1981	3.5	Amityville, NY	1	$11.5M	150
Medicis Pharmaceutical Corporation	1987	4.8	Scottsdale, AZ	1	$721.1M	750
FarmVet	2000	3.5	Franklin, TN	1	$1.6M	15
Salix Pharmaceuticals	1989	4.2	Raleigh, NC	2	$1.1B	1,000
Ortho Dermatologics	-	3.9	Bridgewater, NJ	1	$29.0M	375
Mission Pharmacal	1946	4.3	San Antonio, TX	2	$140.0M	750
Quinnova Pharmaceuticals Including Sarms, Peptides and More	2003	3.4	Newtown, PA	1	$5.3M	75
Schering-Plough Animal Health Corporation	-	3.8	-	-	-	-
Sanofi Biosurgery Inc	2000	4.0	Cambridge, MA	1	-	5,600
Aralez Pharmaceuticals	1996	4.1	New York, NY	1	$105.9M	100
Akrimax Pharmaceuticals	2008	3.4	Cranford, NJ	1	$85.0M	125
Horizon Pharma USA, Inc.	2005	4.6	Deerfield, IL	7	$25.0M	30
Aqua Pharmaceuticals	2004	4.3	West Chester, PA	1	$8.6M	71

Rate Egalet's competitiveness in the market.

Egalet salaries vs competitors

Among Egalet competitors, employees at Salix Pharmaceuticals earn the most with an average yearly salary of $106,558.

Compare Egalet salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Egalet	$69,110	$33.23	-
Topix Pharmaceuticals	$66,803	$32.12	-
Medicis Pharmaceutical Corporation	$73,448	$35.31	-
FarmVet	$66,664	$32.05	-
Salix Pharmaceuticals	$106,558	$51.23	-
Ortho Dermatologics	$89,387	$42.97	-

Compare Egalet job title salaries vs competitors

Company	Highest salary	Hourly salary
Egalet	$51,582	$24.80
Horizon Pharma USA, Inc.	$137,945	$66.32
Salix Pharmaceuticals	$122,771	$59.02
Medicis Pharmaceutical Corporation	$88,263	$42.43
Aralez Pharmaceuticals	$58,758	$28.25
Aqua Pharmaceuticals	$55,945	$26.90
Schering-Plough Animal Health Corporation	$55,317	$26.59
Mission Pharmacal	$54,950	$26.42
Ortho Dermatologics	$54,736	$26.32
Akrimax Pharmaceuticals	$53,430	$25.69
Quinnova Pharmaceuticals Including Sarms, Peptides and More	$53,061	$25.51
Sanofi Biosurgery Inc	$52,758	$25.36
Topix Pharmaceuticals	$52,568	$25.27
FarmVet	$52,436	$25.21

Do you work at Egalet?

Is Egalet able to compete effectively with similar companies?

Egalet jobs

Egalet demographics vs competitors

Compare gender at Egalet vs competitors

Job title	Male	Female
Medicis Pharmaceutical Corporation	51%	49%
Horizon Pharma USA, Inc.	55%	45%
Egalet	-	-

Male

Female

100%

75%

50%

25%

Egalet

Horizon Pharma USA, Inc.

Medicis Pharmaceutical Corporation

25%

50%

75%

100%

Compare race at Egalet vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Horizon Pharma USA, Inc.	61%	13%	12%	8%	5%	9.0
Medicis Pharmaceutical Corporation	60%	15%	10%	10%	5%	9.6

Egalet and similar companies CEOs

CEOBio

Timothy P. Walbert

Horizon Pharma USA, Inc.

Jonah Shacknai

Medicis Pharmaceutical Corporation

Neill “Gobie” Walsdorf

Mission Pharmacal

Carolyn Logan

Salix Pharmaceuticals

Jeffrey S. Day

Quinnova Pharmaceuticals Including Sarms, Peptides and More

Adrian Adams

Aralez Pharmaceuticals

Adrian Adams was appointed POZEN’s Chief Executive Offer and elected to its Board of Directors on June 1, 2015. Prior to joining POZEN, Mr. Adams served as Chief Executive Officer and President of Auxilium Pharmaceuticals, Inc. from December 2011 until its acquisition by Endo International plc in January 2015 for $2.6 billion. Under his leadership, Auxilium transformed into a men’s healthcare company and broadened its portfolio from two to twelve through the strategic corporate acquisition of Actient Holding LLC and product in-licensing. Prior to joining Auxilium, Mr. Adams served as Chairman and Chief Executive Officer of Neurologix, Inc., a company focused on development of multiple innovative gene therapy development programs. Before Neurologix,

Burt Shaffer

Topix Pharmaceuticals